Sun Pharmaceuticals Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe.
| FactSnippet No. 1,484,707 |
Sun Pharmaceuticals was founded by Dilip Shanghvi in 1983 in Vapi, Gujarat, with five products to treat psychiatry ailments.
| FactSnippet No. 1,484,708 |
Sun Pharmaceuticals Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.
| FactSnippet No. 1,484,709 |
Sun Pharmaceuticals Pharma has complemented growth with select acquisitions over the last two decades.
| FactSnippet No. 1,484,710 |
In 1996, Sun purchased a bulk drug manufacturing plant at Ahmednagar from Knoll Pharmaceuticals and MJ Pharma's dosage plant at Halol that are both U S FDA approved today.
| FactSnippet No. 1,484,711 |
In 1997, Sun Pharma acquired Tamil Nadu Dadha Pharmaceuticals Limited based in Chennai, mainly for their extensive gynaecology and oncology brands.
| FactSnippet No. 1,484,712 |
Also in 1997, Sun Pharma initiated their first foray into the lucrative US market with the acquisition of Caraco Pharmaceuticals, based in Detroit.
| FactSnippet No. 1,484,713 |
In 1998, Sun Pharmaceuticals acquired a number of respiratory brands from Natco Pharma.
| FactSnippet No. 1,484,714 |
In 2011, Sun Pharmaceuticals Pharma entered into a joint venture with MSD to bring complex or differentiated generics to emerging markets .
| FactSnippet No. 1,484,715 |
On 6 April 2014, Sun Pharmaceuticals Pharma acquired Ranbaxy in a US$4 billion landmark transaction to create the world's 5th largest specialty generic pharmaceutical company.
| FactSnippet No. 1,484,716 |
In March 2015, Sun Pharmaceuticals Pharma announced it had agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.
| FactSnippet No. 1,484,717 |
From 2016 to 2018, Sun Pharmaceuticals Pharma launched some of its new products in the USA.
| FactSnippet No. 1,484,718 |
In 2019, Sun Pharmaceuticals Pharma acquired Pola Pharma in Japan to strengthen its global dermatology presence.
| FactSnippet No. 1,484,719 |
Sun Pharmaceuticals entered the Greater China market by partnering with China Medical System Holdings as well as launched a speciality product, Cequa, in the United States for the treatment of dry eyes.
| FactSnippet No. 1,484,720 |
Sun Pharmaceuticals Pharma stood second in the India's Most Reputed Brands list in a study conducted by BlueBytes, a leading Media Analytics firm in association with TRA Research, a brand insights organization .
| FactSnippet No. 1,484,721 |